Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06865820 · ClinicalTrials.gov registry record · NA

Implementation and Cost Evaluation of Project UPLIFT

A NA study of Epilepsy, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06865820 is a NA study of Epilepsy that is actively recruiting participants, run by Emory University. The registered enrollment target is 60 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06865820, a NA study of Epilepsy, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study tests Project Using Practice and Learning to Increase Favorable Thoughts (UPLIFT) which is a Mindfulness-based Cognitive Behavioral Therapy program teaching participants with epilepsy methods that include challenging thoughts, behavioral activation, coping, problem-solving, and mindfulness, for well-being and costs. Project UPLIFT is delivered as weekly sessions over 8 weeks.

Conditions Studied

Interventions

  • BEHAVIORAL Project UPLIFT

Study Locations (1)

Georgia

  • Rollins School of Public Health - Atlanta

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-24
Est. Completion 2026-12-15
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT06865820

The ClinicalTrials.gov registry entry for NCT06865820 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (94% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Project UPLIFT is the first listed.

NCT06865820 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06865820 about?

NCT06865820 is a clinical study titled "Implementation and Cost Evaluation of Project UPLIFT". This study tests Project Using Practice and Learning to Increase Favorable Thoughts (UPLIFT) which is a Mindfulness-based Cognitive Behavioral Therapy program teaching participants with epilepsy methods that include challenging thoughts, behavioral activation, coping, problem-solving, and mindfulnes...

What is the current status of trial NCT06865820?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-24. Estimated completion is 2026-12-15.

What conditions does trial NCT06865820 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT06865820?

The interventions under investigation include: Project UPLIFT (BEHAVIORAL).

Who is sponsoring clinical trial NCT06865820?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06865820 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.